Clinical validation PN Medical is pursuing first-of-its-kind studies on Respiratory Muscle Training with The Breather, supported by notable partners. This presents a sales opportunity to leverage clinical data in conversations with hospitals, rehab centers, and payer groups to establish credibility and drive adoption.

Therapy bundle The Breather aims to combine diagnostics, therapeutics, and remote monitoring into a plug-n-play device. Position this as a comprehensive pulmonary rehabilitation solution that can reduce hospital readmissions and support COPD, asthma, heart failure, stroke, and post-COVID recovery programs.

Collaborative partnerships Past and ongoing collaborations with Mayo Clinic, Covid Care Group, and others indicate receptiveness to research and discounted procurement models. Use co-marketing and pilot programs to accelerate trials, expand clinical footprints, and broaden channel partners.

Accessible pricing Revenue range suggests a small to mid-market focus with potential for scalable pricing tiers or bundled offerings for clinics, rehab centers, and telehealth providers. Explore value-based pricing tied to outcomes like reduced COPD exacerbations and improved respiratory function.

Market readiness Interest from diverse patient populations including COPD, asthma, neurological conditions, and post-stroke recovery signals a large potential addressable market. Target multi-specialty rehabilitation departments and home health services with remote monitoring capabilities to expand usage.